Vor Biopharma Inc. Profile Avatar - Palmy Investing

Vor Biopharma Inc.

Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hemato…

Biotechnology
US, Cambridge [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of VOR's Analysis
CIK: 1817229 CUSIP: 929033108 ISIN: US9290331084 LEI: - UEI: -
Secondary Listings
VOR has no secondary listings inside our databases.